*Correspondence: Tina Vilsbll [email protected] This article was submitted to Cellular Endocrinology, a section of the journal Frontiers in Endocrinology Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
The leadership profile that GLP-1 disruption demands is not the one most CPS succession pipelines were built to develop, and that mismatch creates an assessment problem for boards
How to fill a syringe For some medications, you will need to fill a syringe before injecting yourself
From skincare to weight loss and cognitive function, the telehealth provider looks to help you conquer what feels inevitable
Nonarteritic Anterior Ischemic Optic Neuropathy (NAION) Earlier in 2025, a small study in JAMA Ophthalmology focused on eye complications experienced by nine people who took GLP-1 antidiabetic drugs, including semaglutide